Investment
Features
FeesSafety
Academy
More
Pluang+

Compare General Mills, Inc. (GIS) vs NeoGenomics Inc. Common Stock (NEO) Price & Performance

General Mills, Inc.Trade
NeoGenomics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

General Mills, Inc. vs NeoGenomics Inc. Common Stock — how do they compare? General Mills, Inc. trades at $32.25 (market cap $17.02B), while NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B). The key difference: General Mills, Inc. is far larger — about 8× NeoGenomics Inc. Common Stock's market cap, and General Mills, Inc. pays a 7.67% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 107 Days and NeoGenomics Inc. Common Stock for 0 Days on average.

GISNEO
Market Cap
$17.02B$2.14B
Volume
7,979,0672,228,400
Sector
Consumer StaplesHealth
52-Week High
$49.18$19.91
52-Week Low
$31.67$7.19
Typical Hold Time
107 Days0 Days
Enterprise Value
$30.20B$2.44B
Dividend Yield
7.67%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

General Mills, Inc.

General Mills (GIS) trades at $32.11, down 1.8% on the day, reflecting recent pressure from a Q4 2025 earnings miss and a projected net loss for 2026. The stock shows a bearish technical trend, with key support at $32. Despite a low P/E of 9.23, profitability metrics like a negative ROE of -10.55% and a forecasted negative net income margin for 2026 highlight significant challenges. Recent news includes a CEO transition and a reaffirmed $0.61 quarterly dividend, but investor sentiment remains cautious amid declining revenues and margin pressures.

The outlook for GIS is clouded by execution risks in its turnaround strategy and macroeconomic headwinds. The high dividend yield offers income appeal, but the potential for a dividend cut and sustained earnings weakness presents substantial risk. Analyst consensus is predominantly Hold, with a $36 price target suggesting limited near-term upside, making the stock a speculative hold for income-focused investors tolerant of high risk.

NeoGenomics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GIS
1% Buy99% Sell
Avg holding period · 107 Days
NEO
100% Buy0% Sell
Avg holding period · 0 Days

About General Mills, Inc.

General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.

Read more on GIS →

About NeoGenomics Inc. Common Stock

NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.

Read more on NEO →